INLIF Ltd

INLIF Ltd(INLF)股票分析

$0.265

+0.125 (+47.22%)收盤時

Loading chart…
最高
0.299
開盤
0.235
成交量加權均價
0.26
成交量
251.18M
市值
—
最低
0.221
成交金額
65.73M
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

INLIF Ltd is a holding company primarily engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. The Company is also engaged in the provision of installation services and warranty services for manipulator arms, as well as accessories and raw materials for manipulator arms. The Company’s main products include transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms and other products. The Company distributes its products under the brand iNLIF. The Company mainly conducts its business in the domestic market.

AI 分析 of INLIF Ltd (INLF)

賣出

Inlif Limited is not a good buy right now due to its extremely low price of $0.19, a staggering year-to-date change of -99.99%, and a very low RSI of 5.192 indicating oversold conditions. The company has also experienced a significant drop in share price following its reverse stock split, which saw a 39% decline in after-hours trading. While there is a potential for recovery indicated by a projected final change of +18.68%, the current financial instability, including a forward P/E ratio of 0 and a price-to-book ratio of 0.00306, poses a substantial risk. The main risk is the company's drastic decline in share value and negative market sentiment, as evidenced by the 92.48% drop over the last five days. Overall, the combination of these factors suggests that it is better to avoid investing in this asset at this time.

估值指標

INLIF Ltd(INLF)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 INLF 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%INLF

$1.24

情境價格

基

基準

基準 · 50%INLF

$1.20

情境價格

悲

悲觀

悲觀 · 25%INLF

$1.18

情境價格

事件時間軸

2026-10-19 (ET)

10:00:00

Inlif Enters Securities Purchase Agreements for 435,000 Shares

2026-07-07 (ET)

10:00:00

INLIF Ltd Trading Halted Due to Volatility

2026-06-30 (ET)

19:30:00

Stock Futures Mostly Unchanged as Oil Prices Fluctuate

16:30:00

Inlif Approves 1-for-200 Share Combination

2026-06-18 (ET)

08:30:00

Inlif Enters Humanoid Robotics Market

資訊

INLF 常見問題 —— 由 Alphio AI 解答

INLIF Ltd is a holding company primarily engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. The Company is also engaged in the provision of installation services and warranty services for manipulator arms, as well as accessories and raw materials for manipulator arms. The Company’s main products include transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms and other products. The Company distributes its products under the brand iNLIF. The Company mainly conducts its business in the domestic market. It operates in the Industrials sector.

Inlif Limited is not a good buy right now due to its extremely low price of $0.19, a staggering year-to-date change of -99.99%, and a very low RSI of 5.192 indicating oversold conditions. The company has also experienced a significant drop in share price following its reverse stock split, which saw a 39% decline in after-hours trading. While there is a potential for recovery indicated by a projected final change of +18.68%, the current financial instability, including a forward P/E ratio of 0 and a price-to-book ratio of 0.00306, poses a substantial risk. The main risk is the company's drastic decline in share value and negative market sentiment, as evidenced by the 92.48% drop over the last five days. Overall, the combination of these factors suggests that it is better to avoid investing in this asset at this time.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易